Clinical Trial Update: Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating octreotide to improve nutritional recovery after surgery in patients with esophageal or gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: Fredrik Klevebro | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED